Hong Kong Health Authority Warns E-Cigarettes Becoming New Tool for Drug Abuse

Nov.28.2024
Hong Kong Health Authority Warns E-Cigarettes Becoming New Tool for Drug Abuse
The Hong Kong Department of Health has issued a warning that e-cigarettes are becoming a new tool for drug abuse. The cartridges containing illegal drugs resemble regular e-liquid, highlighting the need for legislative restrictions.

According to a report by SCMP on November 27th, the Hong Kong Health Department has warned that e-cigarettes are increasingly being used as a tool for drug abuse, as these devices can easily be filled with drugs and are difficult to detect.

 

The Hong Kong Department of Health's subordinate agency, the Tobacco and Alcohol Control Office, said on Wednesday (27th) that they have recently dealt with cases where the "space oil" in e-cigarette pods appeared to be identical to the e-liquid contained in other products.

 

The head of the office, Dr. Fung Ying, pointed out that: "Those cartridges containing illegal drugs look no different from those with ordinary e-liquid."

 

Space oil" is one of the highly demanded drugs in the city, often found in e-cigarette pods. It contains etomidate, a prescription anesthetic categorized as a Schedule I controlled substance.

 

The Hong Kong government announced a series of proposed measures on June 10, including amending laws to ban the possession of alternative tobacco products. The Department of Health stated that they are currently drafting the details of the legislative proposal and have contacted lawmakers to seek their input. It is expected that these legislative amendments will be submitted to the Legislative Council by the end of 2024 or early 2025.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR—the Research Institute Supporting Juul and NJOY’s successful PMTAs—assessed FDA’s pilot for nicotine pouches. The program expedites premarket review by deferring behavioral data to post-market reporting. CSUR says this could speed authorizations, but manufacturers must still produce behavioral and real-world evidence after a Marketing Granted Order to maintain compliance with public-health standards.
Nov.04
BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
British American Tobacco has paused the U.S. pilot launch of its unlicensed Vuse One vape amid intensified FDA enforcement.
Oct.28 by 2FIRSTS.ai
Japan Tobacco Unveils New Ploom EVO Honey Lemon Smoke Stick, Nationwide Launch in Japan from January 2026
Japan Tobacco Unveils New Ploom EVO Honey Lemon Smoke Stick, Nationwide Launch in Japan from January 2026
Japan Tobacco (JT) has announced a new flavor for its Ploom brand’s premium EVO smoke sticks: “EVO Honey Lemon Crystal.” The product will be rolled out in stages, beginning with an early release through official channels in December 2025, followed by a nationwide launch across convenience stores and tobacco retailers in January 2026, priced at JPY 550 (approximately USD 3.7).
Dec.16 by 2FIRSTS.ai
BAT Malaysia Reports Q3 Results: Net Profit Plummets 89.5%, Stock Price Drops 15%
BAT Malaysia Reports Q3 Results: Net Profit Plummets 89.5%, Stock Price Drops 15%
BAT Malaysia's Q3 results show a sharp 89.5% drop in net profit to RM7 million (approximately $150,000 USD), with revenue also falling to RM300 million (approximately $6.4 million USD). The company attributed the decline to new regulatory requirements, including pictorial health warnings and the retail display ban. Its stock dropped 15.25% to RM4.78 (approximately $1.02 USD).
Oct.31 by 2FIRSTS.ai
Product | HQD launches the new HQD GO in the U.S., featuring three power levels and a ~$30 price tag.
Product | HQD launches the new HQD GO in the U.S., featuring three power levels and a ~$30 price tag.
HQD has listed the disposable HQD GO on its official site and U.S. channels. The device touts 35,000 puffs, three power levels with adjustable airflow, and a 30 mg/ml nicotine strength. On U.S. retail websites, it’s priced at about $29.99.
Oct.24 by 2FIRSTS.ai
Philip Morris USA Reaches $66M Settlement With Washington State Over MSA Payment Dispute
Philip Morris USA Reaches $66M Settlement With Washington State Over MSA Payment Dispute
Philip Morris USA has reached a settlement with Washington State and agreed to pay $66 million to resolve disputes over annual payments under the 1998 Master Settlement Agreement (MSA) for the period 2005–2015.
Nov.04 by 2FIRSTS.ai